IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. - Wikidata - awgldk - TriplyDB

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

http://www.wikidata.org/entity/Q35973404

about

Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer Unraveling insulin-like growth factor binding protein-3 actions in human disease An ocular view of the IGF-IGFBP system The role and interaction of imprinted genes in human fetal growth Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature The mouse retina as an angiogenesis model.Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).Understanding retinopathy of prematurity: update on pathogenesis.Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization.Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions.Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.Transcriptome sequencing reveals differences between primary and secondary hair follicle-derived dermal papilla cells of the Cashmere goat (Capra hircus).IGFBP-3 inhibits TNF-α production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis.Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model.Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model The genetic control of avascular area in mouse oxygen-induced retinopathy A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants Aberrant kinetics of bone marrow-derived endothelial progenitor cells in the murine oxygen-induced retinopathy model.Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium.IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy cGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal Explants TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity?

P2860

Q24604176-AD126172-8681-434E-8FE1-2F712E293F35 Q24650060-F44BB89F-C77F-4C91-9627-EEE3A712C30A Q27013698-A10C6B22-F7FF-489F-AC60-FA63686656B4 Q28083223-1DE989F7-3F9F-489C-B407-D7C8D9889B65 Q28750081-65B71287-D5F0-4B6B-8942-FB13EB6C0877 Q30495106-7DC87C4C-FFCF-4C4F-B089-ECBA5A76194B Q30542079-6C180E0D-0510-4F6B-907A-8CF24A09FA5B Q30968571-F9B51112-901E-4B08-9EC8-408E33576B12 Q33504506-2A02324C-42B6-4BD0-A32E-6BAC65541662 Q33632210-E529D45E-BFCE-4383-A828-9D3B38FBB165 Q33640027-615234D0-BE88-41F1-9B84-F684C5A97077 Q33756365-1A5624EC-E593-4ECE-A8A4-C6BD25AC1ED8 Q33787955-2F8BC6CA-7478-4786-89EA-D851AAFEC106 Q33808187-564B28AD-C3AE-45E7-BA42-498D877DDD2B Q33858783-0075055E-FB95-4D7D-837D-507A8F93A246 Q34022792-403E7C4F-A9D1-4B7C-A6A1-5365056F41AB Q34038976-CFDDA88C-15CD-4E39-838F-5CF4B6E8F2F4 Q34090125-06529209-194E-4DB7-9DCD-15A4187E9C0E Q34122706-985C6C33-2895-4EE4-81AF-6A519C7ADEC7 Q34358139-BC38BE14-C9E9-49C0-ACF6-6EC31EB113B9 Q34533929-0D872257-B35C-4353-A7E1-2F2385EDC41F Q34805398-C25903C4-BA3A-400F-A6CC-8925A7F9B9C0 Q34805681-21CBB739-0C73-4D36-9DF8-C6AD5BC3419B Q34956067-0F3D78D3-0336-43E4-85E9-2BBB8774C035 Q34979016-26B083B2-DCFD-4D58-A784-6F830579E906 Q34999770-8E62FB87-75BC-448B-8E5D-C4F61A3BF197 Q35136744-C5B93E71-8551-4AC2-BF64-A1D0378B0F0B Q35165646-D4E77CD1-EB70-43A9-9465-C794F87DC5EA Q35221114-14F1C3A8-7D5E-4512-835D-C8D486363F41 Q35768528-3BE6B01F-1404-404D-853D-F9463C1F77F2 Q35800245-4925C181-3A27-48FA-83A4-F51C5118816A Q35826633-4B8E411D-A369-486E-B097-63121F3570F9 Q35878260-6EBEED48-3BA3-4ED8-99D3-D022D1055E2A Q35973411-2D370A28-3232-4189-89C6-90CDDD626FDF Q35987892-DF653A03-F8CE-40DB-A50D-540F684A0DAD Q36041947-73F1DBBA-03E5-43A3-A079-F11241549718 Q36044670-38896BD8-BA00-4DB6-BE84-2C59D1D5A84B Q36197680-7C4A45E4-BE69-4C82-9C73-0CE83B775C58 Q36232684-D642A070-8F85-47CC-851D-E05E491517E5 Q36271090-85E2617D-826A-48B2-BDB2-1210E5FBBF8D

P2860

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

http://www.wikidata.org/entity/Q35973404

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.

@ast

IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.

@en

type

label

IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.

@ast

IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.

@en

prefLabel

IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.

@ast

IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.

@en

P1433

Q35973404-B6FF8E3D-EA41-4653-A062-37D0613D5B9A

P1476

Q35973404-68FCA77B-C085-4DBA-9FFD-65D3EBD53061

P2093

Q35973404-8776A7B8-61E9-4669-ADCD-5134748BC9E6

Q35973404-A26ED318-4458-4422-90A3-BC3E12511C18

Q35973404-B38D9421-80F8-4F38-B665-E12B198899E3

Q35973404-B3FDC24D-F05D-4395-A0A7-EBE23209A20D

Q35973404-CADE9654-03CE-421D-B22A-B3090E0F24DE

Q35973404-CCA8442E-5D85-4320-AAA7-B5D7270625B0

Q35973404-FEDFF4E8-BF0F-4867-9BA6-8AB7791A1D4F

P2860

Q35973404-154E011C-5485-4F81-84C5-4D3B8220DA5B

Q35973404-1D9451E4-3C60-4733-9B6F-EAEFD39A9A50

Q35973404-204F98A3-032A-40F9-825C-7F1017F255A6

Q35973404-34BC62BD-483C-442C-8E32-5F5BCB2D08F4

Q35973404-4BE4FAF9-D4FD-4660-BEBA-A6A5B0A6E1AE

Q35973404-592C621B-BE5C-4A12-BBBC-554D971EF05B

Q35973404-6D887EED-98BE-4A4C-A38B-C9A5ACFA7E48

Q35973404-6E5D741B-9145-4FBD-9E39-5E54964D79BF

Q35973404-6E662037-27DD-4A18-8C78-6ADB1A00E01E

Q35973404-75FC7873-AF69-484B-8256-EA52ACE49B76

P304

Q35973404-695A849D-36D2-4ABF-9AF9-E1BA62A8B328

P31

Q35973404-F9D1DE67-6836-4DE9-8D0E-E77FB6E14EFE

P356

Q35973404-1D09D04E-F274-471B-AD8C-7061C0E30496

P407

Q35973404-72829EAA-98A4-4940-8866-9EC7FAC60F1D

P433

Q35973404-FC61C482-5779-4316-BCA2-5C9915E367F2

P478

Q35973404-D0CE5CC9-3BF2-498E-9EAB-FA7583905A8A

P50

Q35973404-35BB0DE4-79DD-4EF1-A69A-57FD741A3ECA

Q35973404-A69FDD05-286A-49FD-9146-71D53F760418

Q35973404-B898840B-FC21-4490-B124-3E92211C5EE9

P577

Q35973404-4E8F26F3-F9B2-4C14-9720-BF971DFFDD13

P5875

Q35973404-AA25A17F-B946-450B-B708-F567CCDCA3EF

P698

Q35973404-97732267-4B6D-49A3-89F7-FB51397D2F6F

P932

Q35973404-0479C9B7-3BFF-4B88-AA20-B4D54C89F9FF

P356

PNAS.0702031104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

IGFBP3 suppresses retinopathy ...... promotion of vascular regrowth

@en

P2093

Alexandra C H Smith

http://www.w3.org/2001/XMLSchema#string

Christopher M Aderman

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

John E Pintar

http://www.w3.org/2001/XMLSchema#string

Lois E H Smith

http://www.w3.org/2001/XMLSchema#string

Nan Liu

http://www.w3.org/2001/XMLSchema#string

Thomas Ludwig

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular actions of the insulin-like growth factor binding proteins

Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways

Insulin-like growth factor-binding protein-3 and breast cancer survival

Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5

IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects

Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival

IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.

The growth hormone hypothesis - 2005 revision.

P304

10589-10594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0702031104

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Chatarina Löfqvist

P577

2007-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6268917

http://www.w3.org/2001/XMLSchema#string

P698

17567756

http://www.w3.org/2001/XMLSchema#string

P932

1965557

http://www.w3.org/2001/XMLSchema#string